NEW YORK (GenomeWeb News) — Eurofins-Medigenomix-MWG Biotech has acquired a 454 Life Sciences Genome Sequencer 20 instrument from Roche and expects to install it next week in Medigenomix’s German research facility, the companies said last week. 
 
By combining the GS20 with the companies’ current sequencing platform, which is “mainly based” on the Sanger method, MWG and Medigenomix will be able to sequence and compare bacterial genomes in “a couple of days.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.